MIR210HG

Across TCGA pan-cancer cohorts, MIR210HG RNA differs between tumor and matched normal tissue in 15 of 18 cancer types tested, making tumor–normal expression one of MIR210HG’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where MIR210HG RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR210HG is over-expressed in tumor, although a few such as THCA and KICH show the opposite, repressed pattern.

KIRC, LUSC, and KIRP are the cancer types where MIR210HG tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR210HG RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+2.750	<.001	12	view →
LUSC	Female	All	+1.761	<.001	8	view →
KIRP	All	II,III,IV	+1.357	<.001	8	view →
THCA	All	II,III,IV	−0.744	<.001	8	view →
UCEC	All	All	+1.654	<.001	6	view →
BLCA	All	All	+1.154	.002	6	view →
KICH	All	All	−1.024	<.001	6	view →
COAD	Male	II,III,IV	+0.825	.006	6	view →
BRCA	All	All	+0.473	<.001	6	view →
LIHC	All	All	+0.617	<.001	5	view →
LUAD	Female	All	+0.562	<.001	5	view →
HNSC	Male	All	+0.621	.024	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 15 lineages.

MIR210HG–KIRC

Open the KIRC breakdown →